NASP Thanks the Senate Finance Committee for Taking Initial Steps to Address Anticompetitive PBM Practices

Urges the Committee to Do More to Support Specialty Pharmacies and Patient Pharmacy Choice

NASP is pleased to share that the Senate Finance Committee took a first step this week towards addressing anticompetitive PBM practices by passing the Modernizing and Ensuring PBM Accountability Act. The bill, which advanced out of committee on Wednesday, includes important provisions meant to address practices that have largely contributed to the growth of pharmacy DIR fees in Medicare Part D and address spread pricing practices in Medicaid – practices that hurt specialty pharmacies, limit network participation and prohibit patient access to the specialty pharmacy of their choosing for management of complex conditions like cancer, multiple sclerosis and rheumatoid arthritis. 

NASP is encouraged by this first step but continues to urge the Senate Finance Committee to include the full bipartisan Protect Patient Access to Pharmacies Act (S. 2052) in the final PBM reform package.

Click here to read the full press release